Lilly Bamlanivimab Antibody Playbook
This antibody playbook provides information for state, territorial and local public health programs to plan and operationalize a bamlanivimab antibody response to COVID-19. The sections of this document cover specific areas of COVID-19 antibody program planning and implementation, as well as links to resources to assist with those efforts.
Related Content
Ensuring Access to Critical Medicines for Children
Reinforcing Readiness: Collaborating to End Drug Shortages
The Pharmacy That Keeps Brynn Dancing
Ensuring Access to Critical Medicines for Children
Discover how Angels for Change partners with manufacturers to prevent shortages and keep lifesaving pediatric drugs available.
Reinforcing Readiness: Collaborating to End Drug Shortages
Learn why the Children’s Hospital Association partners with a nonprofit to ensure medications are always available to patients who depend on them.
The Pharmacy That Keeps Brynn Dancing
The Cincinnati Children’s home care pharmacy is indispensable to children with complex medical conditions.
